Covered recipient · General Payments record
SANDRA N HOLZHAUER-FEENEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,419.81
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.43 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $132.80 | 9 |
| Lilly USA, LLC | $40.79 | 3 |
| Acerta Pharma LLC | $38.97 | 2 |
| Axsome Therapeutics, Inc. | $34.78 | 1 |
| Amgen Inc. | $14.76 | 1 |
| PFIZER INC. | $14.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.05 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717052 | CMS |
| ABBVIE INC. | $25.55 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717054 | CMS |
| ABBVIE INC. | $23.15 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717056 | CMS |
| ABBVIE INC. | $4.41 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717058 | CMS |
| ABBVIE INC. | $4.13 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717060 | CMS |
| ABBVIE INC. | $17.64 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717062 | CMS |
| ABBVIE INC. | $27.26 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717064 | CMS |
| ABBVIE INC. | $7.25 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717066 | CMS |
| ABBVIE INC. | $5.36 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717068 | CMS |
| Amgen Inc. | $14.76 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115729016 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.66 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105785500 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.31 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104279489 | CMS |
| Axsome Therapeutics, Inc. | $34.78 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148318698 | CMS |
| Lilly USA, LLC | $13.46 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135364950 | CMS |
| Lilly USA, LLC | $13.53 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135364952 | CMS |
| Lilly USA, LLC | $13.80 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135342925 | CMS |
| PFIZER INC. | $14.33 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131202109 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.